AGP
ROIV icon

Artia Global Partners’s Roivant Sciences ROIV Stock Holding History

Artia Global Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.59M Hold
129,800
– – 0.85% 28
2026
Q1 		$3.6M Hold
129,800
– – 0.72% 27
2025
Q4 		$2.82M Buy
+129,800
New +$2.56M 0.4% 33
2023
Q4 		– Sell
-914,023
Closed -$10.7M – 34
2023
Q3 		$10.7M Buy
914,023
+89,660
+11% +$1.01M 4.44% 8
2023
Q2 		$8.31M Buy
824,363
+666,600
+423% +$5.96M 2.86% 14
2023
Q1 		$1.16M Buy
+157,763
New +$1.3M 0.43% 26

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Artia Global Partners's ROIV Position: Q2 2026 in Review

Artia Global Partners held its Roivant Sciences (ROIV) position steady in Q2 2026 at 129,800 shares worth $4.59M. The position accounts for 0.85% of the portfolio, ranked #28.

Artia Global Partners first reported a position in ROIV in Q1 2023 and has held it in 6 quarters since. The position peaked at $10.7M in Q3 2023. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Artia Global Partners held 129,800 shares of Roivant Sciences worth $4.59M as of Q2 2026.
  • Artia Global Partners left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.85% of Artia Global Partners's portfolio in Q2 2026, its #28 holding.
  • Artia Global Partners first reported a position in Roivant Sciences in Q1 2023 and has held it in 6 quarters since.
  • Artia Global Partners's Roivant Sciences position peaked at $10.7M in Q3 2023.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.